Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 19;211(2):219–228. doi: 10.4049/jimmunol.2300077

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 by The American Association of Immunologists, Inc.

This article is distributed under The American Association of Immunologists, Inc.,Reuse Terms and Conditions for Author Choice articles.

PMC Copyright notice

FIGURE 4. — Increase of E75- and E90-specific T cell responses in treated patients. Pretreatment immune monitoring measurements were compared with the time point of best response on treatment: (A) frequency of E75-specific CD8⁺ T cells, (B) frequency of CD8⁺ T cells positive for CD107 surface staining after stimulation with E75 peptide, (C) frequency of CD8⁺ T cells expressing IFN-γ after stimulation with E75 peptide, (D) frequency of E90-specific CD8⁺ T cells, (E) frequency of CD8⁺ T cells positive for CD107 surface staining after stimulation with E90 peptide, and (F) frequency of CD8⁺ T cells expressing IFN-γ after stimulation with E90 peptide.